
X4 Pharmaceuticals, Inc (XFOR) Stock Continues Downward Trend Since Disclosure of Positive Preliminary Mavorixafor Data
X4 Pharmaceuticals, Inc. (XFOR) stock prices were down by 8.40% as of the market closing on June 18th, 2021, bringing the price per share down